COMP <GO>
DBD vs GWW // RETURN ON INVESTED CAPITAL (ROIC)
Diebold Nixdorf Incorporated (NYSE) VS. W.W. Grainger Inc. (NYSE) • 15-METRIC TALLY: DBD 3
— GWW 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: GWW
LAST: $56.05 (+1.82%) • MKT CAP: $1.85B
roic
11.50%
LAST: $1,377.66 (+1.36%) • MKT CAP: $64.02B
roic
35.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DBD VS. GWW)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DBD | GWW | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.30% | 39.10% | -13.80 | GWW | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 11.50% | 35.80% | -24.30 | GWW | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.6x | 21.6x | -11.00 | DBD | /valuation <GO> |
| Free Cash Flow Yield | 15.14% | 2.06% | +13.08 | DBD | /fcf-yield <GO> |
| Operating Margin | 6.40% | 13.90% | -7.50 | GWW | /operating-margins <GO> |
| Net Profit Margin | 2.50% | 9.50% | -7.00 | GWW | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 4.50% | -3.00 | GWW | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.72% | -0.72 | GWW | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.79 | 14.74 | -12.95 | GWW | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 33.5 | 59.1 | -25.60 | GWW | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 19.5x | 35.2x | -15.70 | DBD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.85B | $64.02B | -$62.17B | GWW | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DBD REV | GWW REV | DBD GROSS % | GWW GROSS % | DBD FCF | GWW FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.81B | $17.94B | 25.3% | 39.1% | $300.7M | $1.33B |
| FY 2024 | $3.75B | $17.17B | 24.5% | 39.4% | $149.2M | $1.57B |
| FY 2023 | — | $16.48B | — | — | — | $1.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DBD // BETA —
GWW // BETA 0.87